Daniel F Maixner MD MS
Professor, Psychiatry, University of Michigan Medical School
Join to View Full Profile
1500 East Medical Center DrUH-South, F6232Ann Arbor, MI 48109
Phone+1 734-936-9760
Dr. Maixner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Maixner is a psychiatrist in Ann Arbor, MI and is affiliated with Michigan Medicine. He received his medical degree from University of Nebraska College of Medicine and has been in practice 25 years. He is experienced in electroconvulsive therapy, catatonia, transcranial magnetic stimulation, treatment resistant depression, and vagus nerve stimulation.
Education & Training
University of MichiganMS, Clinical Research Design and Statistical Analysis, 2007 - 2009
University of MichiganResidency, Psychiatry, 1992 - 1996
University of Nebraska College of MedicineClass of 1992
Certifications & Licensure
MI State Medical License 1994 - 2028
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Publications & Presentations
PubMed
- Practical Steps: Using Electroconvulsive Therapy in Patients With Neurodevelopmental Disorders and Catatonia.Neera Ghaziuddin, H Yavuz Ince, Hannah Reynard, Alexander Palffy, Daniel F Maixner
The Journal of ECT. 2026-03-12 - 1 citationsCognitive effects of electroconvulsive therapy in depressed adolescents.Neera Ghaziuddin, Shawn M McClintock, Daniel F Maixner, Leslie R Miller, Mustafa Husain
Journal of Affective Disorders. 2024-07-01 - 8 citationsClinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression.Sagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, Eric Achtyes, Fernando S Goes
Journal of Affective Disorders. 2024-03-01
Journal Articles
- Cost-Effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United StatesEric L Ross, Daniel F Maixner, JAMA
Press Mentions
Ketamine Shows Promise for Hard-to-Treat Depression in New StudyMay 26th, 2023- Pandemic Shows Essential Role of ECT as Treatment for Severe DepressionJune 2nd, 2021
- Pandemics Show an Important Role for ECT as a Treatment for Severe DepressionJune 2nd, 2021
Professional Memberships
- International Society for ECT and Neurostimulation (ISEN)Executive Officer-Secretary
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
